IL4 and COVID-19: Since individuals with asthma and allergic diseases, which are not commonly encountered comorbidities in COVID-19, experience overactivation of type 2 immune response, including IL4, it is also proposed that the overexpression of this protein might play a protective role against COVID-19 infection (Liu et al., 2020; Gao et al., 2022).